comparemela.com

Latest Breaking News On - மருந்து வடிவமைப்பு - Page 1 : comparemela.com

Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer

Escalating Need to Reduce Drug Development Costs and Time to Fuel AI Enabled Drug Discovery & Clinical Trials Market

Escalating Need to Reduce Drug Development Costs and Time to Fuel AI Enabled Drug Discovery & Clinical Trials Market A new study by MarkNtel Advisors, the Global AI Enabled Drug Discovery & Clinical Trials Market is likely to witness around 23.6% CAGR during 2021-26. UNITED SATES, July 29, 2021 /EINPresswire.com/ It owes primarily to the rapidly increasing awareness regarding the benefits of AI among medical professionals, the mounting requirements to minimize the drug discovery cost & time, and burgeoning adoption of cloud-based services & applications, owing to which, faster, efficient, & cost-effective drug discovery, is gaining momentum amongst the pharmaceutical industry stakeholders. Apart from this, delay in patent expiry and expansion of biotechnology industries are other crucial factors likely to enhance the market growth in the years to come.

Physicochemical failure modes for Narrow Therapeutic Index (NTI) drugs

Physicochemical failure modes for Narrow Therapeutic Index (NTI) drugs
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

A Vaccine Patch Could Someday Be An Ouchless Option

Listen • 3:51 Mark Prausnitz, Georgia Tech Regents professor in the School of Chemical and Biomolecular Engineering, holds a vaccine patch containing microneedles that dissolve into the skin. It s the rare individual who actually looks forward to getting jabbed with a needle, even if what s in the needle can protect them from a serious disease such as COVID-19. But several teams around the world are working on a way to inject a vaccine without the ouch. The trick is to make the needles small. Really small. So small they don t interact with the nerve endings that signal pain. Mark Prausnitz is director of the Center for Drug Design, Development and Delivery at Georgia Tech. He works on something called microneedle patches to deliver vaccines. So far, he s developed patch vaccines for flu and measles, but the technology could be used for a COVID-19 vaccine as well.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.